Kadcyla Trastuzumab Emtansene 160mg

100,000.00

KADCYLA is a prescription medicine used to treat HER2-positive breast cancer that has spread to other parts of the body (metastatic breast cancer) after prior treatment with trastuzumab (Herceptin®) and a taxane.

Product Details:

Manufacturer Roche
Packaging Size 1’s
Brand Kadcyla
Composition Trastuzumab Emtashine 160mg
Prescription/Non prescription Prescription
Manufactured By Roche
Form Injection
Product Name Kadcyla
Marketed By Roche
Therapeutic Uses A drug used to treat certain patients with HER2-positive breast cancer that has already been treated
Treatment A drug used to treat certain patients with HER2-positive breast cancer that has already been treated
Shopping Cart

No products in the cart.

No products in the cart.